F. Hoffmann-La Roche Ltd has reported that net income attributable to shareholders for the first six months ended June 30, 2015 was CHF5.15 billion, or CHF5.98 per diluted share, compared to CHF5.53 billion, or CHF6.41 per diluted share, for the ... Individual.com, 1 month ago
Roche announces availability of new HTLV-I/II infection diagnostic assay - Individual.com, 1 month ago
FINDINGS FROM F. HOFFMANN-LA ROCHE IN THE AREA OF NON-SMALL CELL LUNG CANCER DESCRIBED (CLINICAL GENOTYPING AND EFFICACY OUTCOMES : exploratory...
Findings from F. Hoffmann-La Roche in the Area of Non-Small Cell Lung Cancer Described (Clinical genotyping and efficacy outcomes: exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in ...) By a ...4 Traders, 1 month ago Global Label-Free Detection Systems Market - Industry Share, Growth, Trends Analysis and Forecast to 2020 Digital Journal, 1 month ago Biosimilars Market by Product (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin)) & Application - Global Forecast to 2020. Research and Markets, 1 month ago Digital PCR (dPCR) and qPCR Market to 2019 - With Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc and F. Hoffmann-La Roche Ltd Dominating the Market Sys-Con Media, 2 weeks ago
Findings from F. Hoffmann-La Roche in Statistics Reported (Approximate Bayesian Model Selection with the Deviance Statistic)
By a News Reporter-Staff News Editor at Journal of Mathematics -- Research findings on Statistics are discussed in a new report. According to news reporting originating in Basel, Switzerland , by VerticalNews journalists, research stated, "Bayesian ...4 Traders, 1 month ago
Study Data from F. Hoffmann-La Roche Provide New Insights into Type 2 Diabetes (Effects of the dual peroxisome proliferator-activated receptor...
Study Data from F. Hoffmann-La Roche Provide New Insights into Type 2 Diabetes (Effects of the dual peroxisome proliferator-activated receptor activator aleglitazar in patients with Type 2 Diabetes mellitus or prediabetes) By a News ...4 Traders, 1 month ago
Switzerland's Roche has entered into an agreement to acquire US-based in vitro diagnostics firm GeneWEAVE BioSciences for around $425m. Under the deal, GeneWEAVE shareholders will receive $190m upfront payment, in addition to around $235m in ...Medical Devices Business Review, 2 weeks ago
Radiology Information Systems Market Report 2015 - Global Trends & Forecast to 2019 for the $700+ Million Industry
_ The global radiology information systems market is estimated at $501.1 Million The global radiology information system market has been segmented based on type, component, deployment mode, end user, and geography. It analyzes competitive ...Sys-Con Media, 10 hours ago
Global Next-Generation Antibody Therapeutics Market is Expected to Grow at 21% CAGR During 2015 - 2020: P&S Market Research
/PRNewswire/ -- The global next-generation antibody therapeutics market was valued at $1,490.0 million in 2014 and it is expected to grow at a CAGR of 20.9% during the period 2015 - 2020. The global next-generation antibody therapeutics market is ...Sys-Con Media, 2 weeks ago
Platelet Aggregation Devices Market by Product (Systems, Reagents, Consumables, Accessories), Application (Research, Diagnostic, CVD, Orthopedic, Trauma), End User (Hospitals, Diagnostic Laboratories, Academia, Blood Banks) - Global Forecasts to 2020
The global platelet aggregation devices market is poised to grow at a CAGR of 21.0% during the forecast period (2015-2020), and is expected to reach a value of ~$342.4 million by 2020. Mature markets (such as the U.S., Germany, France, and the U.K.) ...Global Information Inc, 3 weeks ago
Scientists at The New York Stem Cell Foundation (NYSCF) Research Institute successfully designed a revolutionary, high-throughput, robotic platform that automates and standardizes the process of transforming patient samples into stem cells. This ...Medical Design Technology, 1 month ago NYSCF Global Stem Cell ArrayTM Brings Precision Medicine One Step Closer to the Clinic CNBC, 1 month ago NYSCF Global Stem Cell Array (TM) brings precision medicine one step closer to the clinic Medical News Today, 1 month ago NYSCF Global Stem Cell Array brings precision medicine one step closer to the clinic PhysOrg.com, 1 month ago
Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57
THOUSAND OAKS, Calif. , July 30, 2015 /PRNewswire/ --Amgen ( NASDAQ:AMGN ) today announced financial results for the second quarter of 2015. Key results include: Total revenues increased 4 percent versus the second quarter of 2014 to $5,370 million ...WorldNetDaily, 1 month ago
on your WebpageAdd Widget >Get your members hooked!